271 related articles for article (PubMed ID: 19266271)
1. Molecular characterization of human plasmacytoid dendritic cells.
Cao W
J Clin Immunol; 2009 May; 29(3):257-64. PubMed ID: 19266271
[TBL] [Abstract][Full Text] [Related]
2. Human BDCA2+CD123+CD56+ dendritic cells (DCs) related to blastic plasmacytoid dendritic cell neoplasm represent a unique myeloid DC subset.
Yu H; Zhang P; Yin X; Yin Z; Shi Q; Cui Y; Liu G; Wang S; Piccaluga PP; Jiang T; Zhang L
Protein Cell; 2015 Apr; 6(4):297-306. PubMed ID: 25779340
[TBL] [Abstract][Full Text] [Related]
3. The multifaceted biology of plasmacytoid dendritic cells.
Swiecki M; Colonna M
Nat Rev Immunol; 2015 Aug; 15(8):471-85. PubMed ID: 26160613
[TBL] [Abstract][Full Text] [Related]
4. Plasmacytoid dendritic cells in antiviral immunity and autoimmunity.
Tang F; Du Q; Liu YJ
Sci China Life Sci; 2010 Feb; 53(2):172-82. PubMed ID: 20596824
[TBL] [Abstract][Full Text] [Related]
5. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases.
Gilliet M; Cao W; Liu YJ
Nat Rev Immunol; 2008 Aug; 8(8):594-606. PubMed ID: 18641647
[TBL] [Abstract][Full Text] [Related]
6. Plasmacytoid dendritic cells of the gut: relevance to immunity and pathology.
Lombardi VC; Khaiboullina SF
Clin Immunol; 2014 Jul; 153(1):165-77. PubMed ID: 24769378
[TBL] [Abstract][Full Text] [Related]
7. Characterization of CD56+ dendritic-like cells: a normal counterpart of blastic plasmacytoid dendritic cell neoplasm?
Osaki Y; Yokohama A; Saito A; Tahara K; Yanagisawa K; Ogawa Y; Ishizaki T; Mitsui T; Koiso H; Takizawa M; Uchiumi H; Saitoh T; Handa H; Murakami H; Tsukamoto N; Nojima Y
PLoS One; 2013; 8(11):e81722. PubMed ID: 24312342
[TBL] [Abstract][Full Text] [Related]
8. Physiological role of plasmacytoid dendritic cells and their potential use in cancer immunity.
Schettini J; Mukherjee P
Clin Dev Immunol; 2008; 2008():106321. PubMed ID: 19190769
[TBL] [Abstract][Full Text] [Related]
9. Plasmacytoid dendritic cells in the skin: to sense or not to sense nucleic acids.
Conrad C; Meller S; Gilliet M
Semin Immunol; 2009 Jun; 21(3):101-9. PubMed ID: 19250840
[TBL] [Abstract][Full Text] [Related]
10. Plasmacytoid dendritic cell in immunity and cancer.
Mitchell D; Chintala S; Dey M
J Neuroimmunol; 2018 Sep; 322():63-73. PubMed ID: 30049538
[TBL] [Abstract][Full Text] [Related]
11. TLR ligands upregulate RIG-I expression in human plasmacytoid dendritic cells in a type I IFN-independent manner.
Szabo A; Magyarics Z; Pazmandi K; Gopcsa L; Rajnavolgyi E; Bacsi A
Immunol Cell Biol; 2014 Sep; 92(8):671-8. PubMed ID: 24839978
[TBL] [Abstract][Full Text] [Related]
12. Plasmacytoid dendritic cells: recent progress and open questions.
Reizis B; Bunin A; Ghosh HS; Lewis KL; Sisirak V
Annu Rev Immunol; 2011; 29():163-83. PubMed ID: 21219184
[TBL] [Abstract][Full Text] [Related]
13. Regulatory NLRs Control the RLR-Mediated Type I Interferon and Inflammatory Responses in Human Dendritic Cells.
Fekete T; Bencze D; Szabo A; Csoma E; Biro T; Bacsi A; Pazmandi K
Front Immunol; 2018; 9():2314. PubMed ID: 30344524
[TBL] [Abstract][Full Text] [Related]
14. E-Cadherin Expression and Blunted Interferon Response in Blastic Plasmacytoid Dendritic Cell Neoplasm.
Lorenzi L; Lonardi S; Vairo D; Bernardelli A; Tomaselli M; Bugatti M; Licini S; Arisi M; Cerroni L; Tucci A; Vermi W; Giliani SC; Facchetti F
Am J Surg Pathol; 2021 Oct; 45(10):1428-1438. PubMed ID: 34081040
[TBL] [Abstract][Full Text] [Related]
15. Selective control of type I IFN induction by the Rac activator DOCK2 during TLR-mediated plasmacytoid dendritic cell activation.
Gotoh K; Tanaka Y; Nishikimi A; Nakamura R; Yamada H; Maeda N; Ishikawa T; Hoshino K; Uruno T; Cao Q; Higashi S; Kawaguchi Y; Enjoji M; Takayanagi R; Kaisho T; Yoshikai Y; Fukui Y
J Exp Med; 2010 Apr; 207(4):721-30. PubMed ID: 20231379
[TBL] [Abstract][Full Text] [Related]
16. Innate immune functions of plasmacytoid dendritic cells.
Cao W; Liu YJ
Curr Opin Immunol; 2007 Feb; 19(1):24-30. PubMed ID: 17113765
[TBL] [Abstract][Full Text] [Related]
17. Human plasmacytoid dendritic cells phagocytose, process, and present exogenous particulate antigen.
Tel J; Lambeck AJ; Cruz LJ; Tacken PJ; de Vries IJ; Figdor CG
J Immunol; 2010 Apr; 184(8):4276-83. PubMed ID: 20304825
[TBL] [Abstract][Full Text] [Related]
18. Activation of human plasmacytoid dendritic cells by TLR9 impairs Fc gammaRII-mediated uptake of immune complexes and presentation by MHC class II.
Benitez-Ribas D; Tacken P; Punt CJ; de Vries IJ; Figdor CG
J Immunol; 2008 Oct; 181(8):5219-24. PubMed ID: 18832675
[TBL] [Abstract][Full Text] [Related]
19. Novel markers of normal and neoplastic human plasmacytoid dendritic cells.
Marafioti T; Paterson JC; Ballabio E; Reichard KK; Tedoldi S; Hollowood K; Dictor M; Hansmann ML; Pileri SA; Dyer MJ; Sozzani S; Dikic I; Shaw AS; Petrella T; Stein H; Isaacson PG; Facchetti F; Mason DY
Blood; 2008 Apr; 111(7):3778-92. PubMed ID: 18218851
[TBL] [Abstract][Full Text] [Related]
20. Functions of TGF-β-exposed plasmacytoid dendritic cells.
Saas P; Perruche S
Crit Rev Immunol; 2012; 32(6):529-53. PubMed ID: 23428227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
